Mirae Asset Global ETFs Holdings’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Mirae Asset Global ETFs Holdings's DGX Position: Q2 2026 in Review
Mirae Asset Global ETFs Holdings increased its Quest Diagnostics (DGX) stake by 8.8% in Q2 2026, buying an estimated $353K and bringing the position to 22,202 shares worth $4.71M. The position accounts for 0.01% of the portfolio, ranked #883.
Mirae Asset Global ETFs Holdings first reported a position in DGX in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.89M in Q3 2024. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Mirae Asset Global ETFs Holdings held 22,202 shares of Quest Diagnostics worth $4.71M as of Q2 2026.
- Mirae Asset Global ETFs Holdings bought 1,799 Quest Diagnostics shares in Q2 2026, an estimated $353K.
- Quest Diagnostics made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #883 holding.
- Mirae Asset Global ETFs Holdings first reported a position in Quest Diagnostics in Q2 2024 and has held it in 9 quarters since.
- Mirae Asset Global ETFs Holdings's Quest Diagnostics position peaked at $7.89M in Q3 2024.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.